Topics

Articles

Hub service providers look to telehealth to expand patient connectivity

Patient support in the pandemic era

Commercial teams can prepare for overcoming predictable hurdles

Navigating the patient journey after rare disease diagnosis

When a physician prescribes or treats a patient with your specialty drug, the stakes are high for everyone. Patient access is evolving to improve the patient and physician journey with specialty therapies

Evolving Patient Access Programs for Specialty Therapies

For sessions with co-workers or clients, consider these recommendations

Tips on running virtual meetings

US list-price sales reached $510 billion in 2019

Sales growth of pharmaceuticals is slowing globally, says IQVIA annual study

CoverMyMeds report gives evidence of ongoing difficulties in patient support

Specialty pharmaceutical patients ‘have difficulty’ obtaining their first dose

PCMA study disputes its members’ harm to brick-and-mortar businesses

Pondering the shrinking number of retail pharmacies

Dramatic growth tracks the flood of new specialty    pharmaceuticals entering the market

2020 Patient Support / Hub  Services Report

Clarivate Analytics predicts both approvals and commercial potential

‘Drugs to Watch’ list tags 11 about-to-be-approved therapies with blockbuster potential

Deal with Evoke Pharmaceuticals anticipates FDA approval

Commercial Channels